Charlotte’s Web Holdings has a new chief science officer

Charlotte’s Web Holdings has a new chief science officer

The cannabis company is adding new science talent to help it continue to innovate

A chief scientific officer (CSO) is generally responsible for establishing and executing a strategy within a company for conducting research and developing new scientific discoveries. For a company like Charlotte’s Web, this position is of utmost importance, as for many years, it has focused on developing new products to bring to the cannabis market. The market leader in cannabidiol hemp extract (CBD) believes that Marcel Bonn-Miller, Ph.D. has what it takes to handle the duties and responsibilities of this position.

Leadership is often essential in this role, as the CSO must be able to answer to a chief executive officer (CEO) and deal with issues related to managers or employees in lower positions. Bonn-Miller’s more than two decades of experience in marijuana and cannabinoid research appear to be sufficient to carry that burden. Prior to joining this huge firm, Bonn-Miller had a major four-year stint with Canopy Growth Corporation, most recently as VP of human and animal research.

In addition to his work at one of today’s most powerful multi-state operators (MSO), Bonn-Miller held positions as Director of Cannabinoid Research at Zynerba Pharmaceuticals. Now that his name appears alongside Charlotte’s Web’s top executives, Bonn-Miller will lead the company’s R&D portfolio, including preclinical and clinical research, new product development, alternative botanical wellness and scientific regulatory support.

“We are honored to have Dr. Bonn-Miller join Charlotte’s Web to lead our clinical science initiatives,” said Jacques Tortoroli, CEO of Charlotte’s Web. “His unparalleled clinical research record in cannabinoids is highly applicable for supporting our regulatory and scientific ambitions.”

Bonn-Miller’s extensive research in the field has earned him numerous research grants and recognition awards, including Americans for Safe Access Researcher of the Year. More than 150 research articles on cannabinoid science appear under his name, in addition to co-authoring three patents related to the use of CBD in the treatment of psychological illnesses.

Social Media Auto Publish Powered By :